About Hopital Neurologique Pierre Wertheimer
L'hôpital Pierre-Wertheimer est un hôpital situé à Bron dans la Métropole de Lyon, dans le groupement hospitalier Est.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
25
Hospices Civils de Lyon
18
European Organisation for Research and Treatment of Cancer - EORTC
6
Boehringer Ingelheim
4
Ipsen
4
Washington University School of Medicine
4
Assistance Publique - Hôpitaux de Paris
3
Genentech, Inc.
3
Institut National de la Santé Et de la Recherche Médicale, France
3
University Hospital, Grenoble
3
University Hospital, Lille
3
Clinical Trials at Hopital Neurologique Pierre Wertheimer
During the past decade, Hopital Neurologique Pierre Wertheimer conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 29 clinical trials were completed, i.e. on
average, 31.9% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 16 clinical trials were completed. i.e. 47.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis
2005-06-01
2012-04-01
Unknown status
300
Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia
2004-01-01
Unknown status
90
Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder
2001-03-01
Unknown status
70
FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
2001-09-01
2008-08-01
Terminated
500
Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
2005-05-01
2020-05-01
Completed
175
Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies
2004-05-01
2006-12-01
Terminated
1,700
Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients
2000-09-01
2002-07-15
Completed
63
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hopital Neurologique Pierre Wertheimer" #1 sponsor was "Hoffmann-La Roche" with 25 trials, followed by "Hospices Civils de Lyon" with 18 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Ipsen"
with 4 trials sponsored. Other sponsors include 87 different institutions and
companies that sponsored additional 67 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Neurologique Pierre Wertheimer"
#1 collaborator was "Alzheimer's Association" with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 3 trials as a collaborator and "Hoffmann-La Roche" with 3 trials as a collaborator. Other collaborators include 38 different institutions and companies that were
collaborators in the rest 40 trials.
Clinical Trials Conditions at Hopital Neurologique Pierre Wertheimer
According to Clinical.Site data, the most researched conditions in "Hopital Neurologique Pierre Wertheimer" are
"Multiple Sclerosis" (12 trials), "Parkinson's Disease" (11 trials), "Alzheimer Disease" (10 trials), "Alzheimer's Disease" (10 trials) and "Amyotrophic Lateral Sclerosis" (7 trials). Many other conditions were trialed in "Hopital Neurologique Pierre Wertheimer" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Neurologique Pierre Wertheimer
Most popular intervention types in "Hopital Neurologique Pierre Wertheimer" are "Drug" (89 trials), "Other" (21 trials), "Biological" (17 trials), "Device" (14 trials) and "Radiation" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (38 trials), "Ocrelizumab" (11 trials), "Gantenerumab" (8 trials), "Temozolomide" (7 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Neurologique Pierre Wertheimer
The vast majority of trials in "Hopital Neurologique Pierre Wertheimer" are
147 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Hopital Neurologique Pierre Wertheimer
Currently, there are NaN active trials in "Hopital Neurologique Pierre Wertheimer".
3 are not yet recruiting,
32 are recruiting,
17 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 64 completed trials in Hopital Neurologique Pierre Wertheimer,
1 suspended trials,
and 20 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Neurologique Pierre Wertheimer, 2 "Phase 1"
clinical trials were conducted, 37 "Phase 2" clinical
trials and 62 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 16 trials that are defined as “Not Applicable".
Departments of Hopital Neurologique Pierre Wertheimer
Hopital Neurologique Pierre Wertheimer has several departments that took part in Clinical trials: "Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer Cellule Mutualisée de Recherche Clinique (CMRC)" - 4 trials
Departments List